ABCB5-positive dermal mesenchymal stromal cells

ABCB5-positive dermal mesenchymal stromal cells · RHEACELL GmbH & Co. KG

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ABCB5-positive dermal mesenchymal stromal cells, covering 2025-12-04 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III) [Phase 3]

See pricing